Growth Metrics

Haemonetics (HAE) Work In Process (2011)

Haemonetics' quarterly Work In Process came in at $4.3 million in Q4 2011, down 17.21% quarter-over-quarter from $5.2 million in Q3 2011.

Haemonetics has reported Work In Process for 1 years, with the latest figure at $4.3 million in Q4 2011.

  • For the quarter ending Q4 2011, Work In Process changed N/A year-over-year to $4.3 million; the trailing twelve-month figure through Oct 2011 stood at $4.3 million (changed N/A YoY), and the FY2011 full-year result was $4.4 million, changed N/A from the prior year.
  • Work In Process for Q4 2011 stood at $4.3 million, down from $5.2 million in the prior quarter.
  • The five-year high for Work In Process was $5.2 million in Q3 2011, with the low at $4.3 million in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Haemonetics 3.18 Bn 2.93 Bn 198.21 Mn

Historic Data

Download Data 🔒
DateValue
Oct 1, 2011 4.30 Mn
Jul 2, 2011 5.20 Mn
Apr 2, 2011 4.35 Mn